Page last updated: 2024-09-03

5-ethynyl-1-ribofuranosylimidazole-4-carboxamide and aristeromycin

5-ethynyl-1-ribofuranosylimidazole-4-carboxamide has been researched along with aristeromycin in 1 studies

Compound Research Comparison

Studies
(5-ethynyl-1-ribofuranosylimidazole-4-carboxamide)
Trials
(5-ethynyl-1-ribofuranosylimidazole-4-carboxamide)
Recent Studies (post-2010)
(5-ethynyl-1-ribofuranosylimidazole-4-carboxamide)
Studies
(aristeromycin)
Trials
(aristeromycin)
Recent Studies (post-2010) (aristeromycin)
210272013

Protein Interaction Comparison

ProteinTaxonomy5-ethynyl-1-ribofuranosylimidazole-4-carboxamide (IC50)aristeromycin (IC50)
AdenosylhomocysteinaseHomo sapiens (human)2.1577

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Clercq, E; González, M; Jashés, M; López-Lastra, M; Sandino, A1

Other Studies

1 other study(ies) available for 5-ethynyl-1-ribofuranosylimidazole-4-carboxamide and aristeromycin

ArticleYear
Inhibitors of infectious pancreatic necrosis virus (IPNV) replication.
    Antiviral research, 1996, Volume: 29, Issue:2-3

    Topics: Adenosine; Adenosylhomocysteinase; Amides; Animals; Antiviral Agents; Cell Line; DNA; Foscarnet; Hydrolases; IMP Dehydrogenase; Infectious pancreatic necrosis virus; Orotidine-5'-Phosphate Decarboxylase; Pyrazoles; Ribavirin; Ribonucleosides; Ribose; Salmon; Viral Plaque Assay; Virus Replication

1996